2'-Deoxycytidine Hydrochloride Protection of Mice Against the Lethal Toxicity of Cytosine Arabinoside. Absence of Protection of Bone Marrow Lymphocytes

Overview

Journal Cancer Chemother Pharmacol

Specialty Oncology

Date 1979 Jan 1

PMID 535131

Citations 2

Authors

V M Buchman

N I Belyanchikova

D M Mkheidze

T A Litovchenko

M R Lichinitser

M F Barkhotkina

G J Svet-Moldavsky

Affiliations

Soon will be listed here.

Citing Articles

Cytosine arabinoside triphosphate production in human leukaemic myeloblasts: interactions with deoxycytidine.

Harris A, Grahame-Smith D Cancer Chemother Pharmacol. 1981; 5(3):185-92.

PMID: 6945922 DOI: 10.1007/BF00258478.

Effect of deoxycytidine on the in vitro response of human leukemia cells to inhibitors of de novo pyrimidine biosynthesis.

Bhalla K, Grant S Cancer Chemother Pharmacol. 1987; 19(3):226-32.

PMID: 3581416 DOI: 10.1007/BF00252977.

References

Chimishkian K, Belianchikova N, Kostrykina V, Meiland E . [Influence of Brucella abortus on the course of acute myeloid leukemia in mice]. Vopr Virusol. 1977; (2):202-6. View

Hoshino A, Albrecht A, Hutchison D . Fate of amethopterin-resistant mutants in L1210 mouse leukemia populations. Cancer Res. 1966; 26(5):974-8. View

SCHRECKER A, MEAD J, Urshel M . Isolation and antileukemic activity, in mice, of 1-beta-D-arabinofuranosylcytosine 5'-phosphate present in synthetic 5'-cytidylic acid. Biochem Pharmacol. 1966; 15(10):1443-52. DOI: 10.1016/0006-2952(66)90189-4. View

Evans J, MENGEL G . THE REVERSAL OF CYTOSINE ARABINOSIDE ACTIVITY IN VIVO BY DEOXYCYTIDINE. Biochem Pharmacol. 1964; 13:989-94. DOI: 10.1016/0006-2952(64)90095-4. View

Tattersall M, Brown B, Frei 3rd E . The reversal of methotrexate toxicity by thymidine with maintenance of antitumour effects. Nature. 1975; 253(5488):198-200. DOI: 10.1038/253198a0. View

Svet-Moldavskii G, PAVLOTSKII A, Ravkina L . [The principle of selective protection in chemotherapy of malignant tumors]. Vestn Akad Med Nauk SSSR. 1967; 22(5):42-8. View

Griswold D, Heppner G, Calabresi P . Selective suppression of humoral and cellular immunity with cytosine arabinoside. Cancer Res. 1972; 32(2):298-301. View

GELLHORN A, HIRSCHBERG E, KELLS A . The effect of purines, nucleosides, and nucleotides on the carcinostatic action of 8-azaguanine. J Natl Cancer Inst. 1954; 14(4):935-9. View

Mark J, Calabresi P . Regional protection in cancer chemotherapy. II. Preliminary studies with hypogastric artery infusion of thymidine during treatment with 5-iodo-2'-deoxyuridine. Cancer Chemother Rep. 1962; 16:545-51. View

10.

Dollinger M, Burchenal J, Kreis W, Fox J . Analogs of 1-beta-D-arabinofuranosylcytosine. Studies on mechanisms of action in Burkitt's cell culture and mouse leukemia, and in vitro deamination studies. Biochem Pharmacol. 1967; 16(4):689-706. DOI: 10.1016/0006-2952(67)90082-2. View

11.

Burchenal J, Adams H, Newell N, Fox J . Comparative activity of 1-beta-d-arabinofuranosyl-5-fluorocytosine and related compounds against transplanted mouse leukemias in vivo and in vitro. Cancer Res. 1966; 26(3):370-3. View

12.

Heppner G, Calabresi P . Suppression by cytosine arabinoside of serum-blocking factors of cell-mediated immunity to syngeneic transplants of mouse mammary tumors. J Natl Cancer Inst. 1972; 48(4):1161-7. View

13.

Chaube S, Kreis W, Uchida K, Murphy M . The teratogenic effect of 1-beta-D-arabinofuranosylcytosine in the rat. Protection by deoxycytidine. Biochem Pharmacol. 1968; 17(7):1213-6. DOI: 10.1016/0006-2952(68)90058-0. View

14.

Buchman V, Lichinitser M, Mkheidze D . Selective chemotherapy for advanced murine L 1210 leukemia by combination of 2' deoxycytidine and lethal doses of cytosine-arabinoside. Biomedicine. 1977; 27(5):179-80. View

15.

Gray G, Perper R, Mickelson M, Crim J, Zukowski C . The immunosuppressive activity of ara-cytidine (cytarabine). 3. Effects of canine renal allograft rejection and hemagglutinin formation. Transplantation. 1969; 7(3):183-7. DOI: 10.1097/00007890-196903000-00004. View

16.

Griswold D, Kopp J, Manning J, Heppner G . Correction of a murine mammary tumor virus-associated immunological depression by selective immunosuppression with cytosine arabinoside. Cancer Res. 1975; 35(10):2670-3. View

17.

Momparler R . A model for the chemotherapy of acute leukemia with 1-beta-D-arabinofuranosylcytosine. Cancer Res. 1974; 34(8):1775-87. View

18.

Fischer D, CASSIDY E, WELCH A . Immunosuppression by pyrimidine nucleoside analogs. Biochem Pharmacol. 1966; 15(8):1013-22. DOI: 10.1016/0006-2952(66)90265-6. View

19.

Goldin A, Venditti J, HUMPHREYS S, Dennis D, Mantel N . Studies on the management of mouse leukemia (L1210) with antagonists of folic acid. Cancer Res. 1955; 15(11):742-7. View

20.

BERENBAUM M . PROLONGATION OF HOMOGRAFT SURVIVAL BY METHOTREXATE WITH PROTECTION AGAINST TOXICITY BY FOLINIC ACID. Lancet. 1964; 2(7374):1363-5. DOI: 10.1016/s0140-6736(64)91157-2. View